Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Tables)

9 Months Ended

Aug. 31, 2012


	Three Months Ended						Nine Months Ended
	August 31, 2012			August 31, 2011			August 31, 2012			August 31, 2011
Numerator:
Net Loss	($	547,097	)	($	2,382,416	)	($	5,454,090	)	($	1,971,568	)

Denominator:
Weighted-average shares outstanding-basic		11,166,496			11,757,803			11,325,280			11,754,324
Dilutive common shares issuable upon exercise of stock options		—			—			—			—

Weighted-average shares-diluted		11,166,496			11,757,803			11,325,280			11,754,324

Net loss per common share:
Basic	($	.05	)	($	.20	)	($	.48	)	($	.17	)

Diluted	($	.05	)	($	.20	)	($	.48	)	($	.17	)